These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 27266066)

  • 1. [Rho/Rho-kinase].
    Kawanami D
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():77-83. PubMed ID: 27266066
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice.
    Nuno DW; Harrod JS; Lamping KG
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1469-77. PubMed ID: 19666843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term diabetic complications may be ameliorated by targeting Rho kinase.
    Zhou H; Li Y
    Diabetes Metab Res Rev; 2011 May; 27(4):318-30. PubMed ID: 21309060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked increase of insulin gene transcription by suppression of the Rho/Rho-kinase pathway.
    Nakamura Y; Kaneto H; Miyatsuka T; Matsuoka TA; Matsuhisa M; Node K; Hori M; Yamasaki Y
    Biochem Biophys Res Commun; 2006 Nov; 350(1):68-73. PubMed ID: 16996478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Normalization of sorbitol dehydrogenase activity--an important factor in the treatment of neuropathies and angiopathies in patients with diabetes mellitus].
    Efimov AS; Tkach SN
    Vrach Delo; 1986 Jun; (6):62-4. PubMed ID: 3750965
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of protein kinase C activation and the vascular complications of diabetes.
    Das Evcimen N; King GL
    Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct dysfunctions in diabetic mouse mesenteric artery contraction are caused by changes in the Rho A-Rho kinase signaling pathway.
    Nobe K; Hashimoto T; Honda K
    Eur J Pharmacol; 2012 May; 683(1-3):217-25. PubMed ID: 22465314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacology of aldose reductase inhibitors.
    Kador PF; Robison WG; Kinoshita JH
    Annu Rev Pharmacol Toxicol; 1985; 25():691-714. PubMed ID: 3923907
    [No Abstract]   [Full Text] [Related]  

  • 9. Rho-GTPase and Atherosclerosis: Pleiotropic Effects of Statins.
    Cai A; Zhou Y; Li L
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124206
    [No Abstract]   [Full Text] [Related]  

  • 10. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
    Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protein kinase C pathway].
    Kitada M; Koya D
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():61-6. PubMed ID: 27266063
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of exercise training and RhoA/ROCK inhibition on plaque in ApoE-/- mice.
    Matsumoto A; Manthey HD; Marsh SA; Fassett RG; de Haan JB; Rolfe BE; Coombes JS
    Int J Cardiol; 2013 Aug; 167(4):1282-8. PubMed ID: 22525349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative management of diabetes mellitus.
    Miller J; Watts LF
    Contemp Anesth Pract; 1980; 3():91-107. PubMed ID: 6783367
    [No Abstract]   [Full Text] [Related]  

  • 14. High glucose-induced upregulation of Rho/Rho-kinase via platelet-derived growth factor receptor-beta increases migration of aortic smooth muscle cells.
    Akiyama N; Naruse K; Kobayashi Y; Nakamura N; Hamada Y; Nakashima E; Matsubara T; Oiso Y; Nakamura J
    J Mol Cell Cardiol; 2008 Aug; 45(2):326-32. PubMed ID: 18561944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical trial of glypizide].
    Cañadell Vidal J
    Rev Iber Endocrinol; 1974 Jan; 21(121):61-73. PubMed ID: 4826383
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of Rho-ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase.
    Krijnen PA; Sipkens JA; Molling JW; Rauwerda JA; Stehouwer CD; Muller A; Paulus WJ; van Nieuw Amerongen GP; Hack CE; Verhoeven AJ; van Hinsbergh VW; Niessen HW
    J Mol Cell Cardiol; 2010 Nov; 49(5):781-90. PubMed ID: 20691698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin induces Rho/ROCK-dependent activation of Smads 1/5/8 in pulmonary artery smooth muscle cells.
    Liu Y; Ren W; Warburton R; Toksoz D; Fanburg BL
    FASEB J; 2009 Jul; 23(7):2299-306. PubMed ID: 19244313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired cAMP and Rac 1 signaling contribute to TNF-alpha-induced endothelial barrier breakdown in microvascular endothelium.
    Schlegel N; Waschke J
    Microcirculation; 2009 Aug; 16(6):521-33. PubMed ID: 19504398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells.
    Gutjahr MC; Rossy J; Niggli V
    Exp Cell Res; 2005 Aug; 308(2):422-38. PubMed ID: 15950966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemic drugs.
    Stehling L
    Clin Anesth; 1974; 10(1):233-47. PubMed ID: 4598996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.